Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
5 | 42822843 | intron variant | T/C | snv | 8.4E-03 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.807 | 0.200 | 5 | 42800706 | 3 prime UTR variant | C/T | snv | 0.31 | 0.26 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2010 | 2014 | ||||||
|
0.807 | 0.200 | 5 | 42800706 | 3 prime UTR variant | C/T | snv | 0.31 | 0.26 |
|
Neoplasms; Male Urogenital Diseases | 0.020 | 1.000 | 2 | 2010 | 2014 | ||||||
|
5 | 42827999 | intron variant | G/A | snv | 0.31 |
|
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
0.925 | 0.080 | 5 | 42804013 | intron variant | T/C | snv | 0.14 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.925 | 0.080 | 5 | 42804013 | intron variant | T/C | snv | 0.14 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.160 | 5 | 42801166 | missense variant | C/A;T | snv | 4.0E-06; 0.20 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.827 | 0.160 | 5 | 42801166 | missense variant | C/A;T | snv | 4.0E-06; 0.20 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.827 | 0.160 | 5 | 42801166 | missense variant | C/A;T | snv | 4.0E-06; 0.20 |
|
0.010 | 1.000 | 1 | 2014 | 2014 | ||||||||
|
0.827 | 0.160 | 5 | 42801166 | missense variant | C/A;T | snv | 4.0E-06; 0.20 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.160 | 5 | 42801166 | missense variant | C/A;T | snv | 4.0E-06; 0.20 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.827 | 0.160 | 5 | 42801166 | missense variant | C/A;T | snv | 4.0E-06; 0.20 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.160 | 5 | 42801166 | missense variant | C/A;T | snv | 4.0E-06; 0.20 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
5 | 42810037 | intron variant | A/C | snv | 0.22 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||||||
|
0.807 | 0.200 | 5 | 42800706 | 3 prime UTR variant | C/T | snv | 0.31 | 0.26 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||||
|
0.807 | 0.200 | 5 | 42800706 | 3 prime UTR variant | C/T | snv | 0.31 | 0.26 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.807 | 0.200 | 5 | 42800706 | 3 prime UTR variant | C/T | snv | 0.31 | 0.26 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||||
|
0.807 | 0.200 | 5 | 42800706 | 3 prime UTR variant | C/T | snv | 0.31 | 0.26 |
|
0.010 | 1.000 | 1 | 2014 | 2014 |